Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

AI-based Echocardiography for Detection of Cardiac Amyloidosis | MicrobiomeTrials

← Back to trials

NCT07529860

AI-based Echocardiography for Detection of Cardiac Amyloidosis

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-01Est. Completion: 2028-04

Enrollment target: 200 participants

Contact

Victoria Delgado Garcia, MD, PhDvdelgadog.germanstrias@gencat.cat +3493 497 8436

Other microbiome trials you might be interested in

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's DiseasePhase 1Recruiting

Alzheimer's Disease

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia i…

Irvine, United StatesEst. completion Apr 2030

View Trial →

Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR CarriersRecruiting

Amyloidosis, HereditaryAmyloidosis CardiacAmyloidosis, FamilialTransthyretin-Related (ATTR) Familial Amyloid CardiomyopathyTransthyretin Gene Mutation

Approximately 1.5 million of the 44 million Blacks in the United States are carriers of the valine-to-isoleucine substit…

New York, United StatesEst. completion Jun 30, 2027

View Trial →

Prevalence of Cardiac Thrombi in Cardiac AmyloidosisRecruiting

Cardiac Amyloidosis

Cardiac amyloidosis (CA) is an infiltrative disease characterized by deposits of amyloid proteins of genetic or acquired…

Dijon, FranceEst. completion Jul 2028

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.